Literature DB >> 15923163

Occurrence of c-kit+ tumor cells in hepatitis B virus-associated hepatocellular carcinoma.

Eung Seok Lee1, Eun Mee Han, Young-Sik Kim, Bong Kyung Shin, Chul Hwan Kim, Han Kyeom Kim, Nam Hee Won, Bom Woo Yeom, Insun Kim, Anthony S-Y Leong.   

Abstract

Progenitor cells, termed oval cells, are involved in the pathogenesis of hepatocellular carcinoma (HCC) in animal models. By immunolabeling for c-kit and CD34 in human hepatitis B virus-associated cirrhosis with HCC (50 cases) and those with cirrhosis alone (10 cases), we found c-kit+ tumor cells in tumor tissue in 40 of 50 HCCs. The proportion was less than 0.1% of total tumor cell volume in most HCCs. Immunostaining for c-kit also was detected in sinusoidal endothelial cells in 43 of 50 HCCs. The incidence of oval cell occurrence in the adjacent nonneoplastic tissue in cases of HCC was high (44/50). The occurrence of oval cells, c-kit+ tumor cells, and c-kit+ sinusoidal cells in cases of human hepatitis B virus-associated HCC suggests that oval cell proliferation might be associated with the development of human hepatitis B virus-associated HCC. Furthermore, the c-kit+ sinusoidal cells might have a role in angiogenesis and progression of human hepatitis B virus-associated HCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15923163     DOI: 10.1309/LETTWN3LUF516

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Hepatitis B virus X protein increases the Cdt1-to-geminin ratio inducing DNA re-replication and polyploidy.

Authors:  Lova Rakotomalala; Leo Studach; Wen-Horng Wang; Gerald Gregori; Ronald L Hullinger; Ourania Andrisani
Journal:  J Biol Chem       Date:  2008-08-08       Impact factor: 5.157

Review 2.  The potential role of liver stem cells in initiation of primary liver cancer.

Authors:  Xiao-Song Zhi; Jun Xiong; Xiao-Yuan Zi; Yi-Ping Hu
Journal:  Hepatol Int       Date:  2016-05-02       Impact factor: 6.047

3.  Polo-like kinase 1 inhibition suppresses hepatitis B virus X protein-induced transformation in an in vitro model of liver cancer progression.

Authors:  Leo L Studach; Lova Rakotomalala; Wen-Horng Wang; Ronald L Hullinger; Stefano Cairo; Marie-Annick Buendia; Ourania M Andrisani
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

4.  Infection of hepatitis B virus in extrahepatic endothelial tissues mediated by endothelial progenitor cells.

Authors:  Qifei Rong; Jun Huang; Enben Su; Jun Li; Jianyong Li; Lili Zhang; Kejiang Cao
Journal:  Virol J       Date:  2007-04-02       Impact factor: 4.099

Review 5.  The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy.

Authors:  Yanhong Xiao; Mei Lin; Xingmao Jiang; Jun Ye; Ting Guo; Yujuan Shi; Xuefeng Bian
Journal:  Anal Cell Pathol (Amst)       Date:  2017-07-27       Impact factor: 2.916

6.  Overexpression of c-kit(CD117), relevant with microvessel density, is an independent survival prognostic factor for patients with HBV-related hepatocellular carcinoma.

Authors:  Weiwei Yan; Zhenyu Zhu; Fei Pan; Ang Huang; Guang-Hai Dai
Journal:  Onco Targets Ther       Date:  2018-03-07       Impact factor: 4.147

Review 7.  TWEAK and LTβ Signaling during Chronic Liver Disease.

Authors:  Benjamin J Dwyer; John K Olynyk; Grant A Ramm; Janina E E Tirnitz-Parker
Journal:  Front Immunol       Date:  2014-02-13       Impact factor: 7.561

Review 8.  Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Authors:  Doudou Li; Changhao Chen; Yu Zhou; Rufu Chen; Xinxiang Fan; Zhuofei Bi; Zhihua Li; Yimin Liu
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.